PHSZX (Pru Jenn Health Sci;Z)
Net Asset Value: 34.57
1-Day Return:
-0.08 (-0.23%)
YTD Return as of 4/5/13:
17.03%
Classification: Health/Biotech Objective: Health/Biotech Open to New Investors: No
Lipper Rating
The Lipper Leader system ranks a fund in the following categories: Total Return; Consistent Return; Preservation; Tax Efficiency; and Expenses. Funds are rated in ascending order on a numeric scale of 1 to 5, with '1' representing funds with the lowest rating, and '5' representing the highest rated funds and funds that are Lipper Leaders. Click here for more detail.
| Growth of $10,000
Total Returns (As of 4/05/2013)
More| YTD | 1Yr | 3Yr | 5Yr | 10Yr | |
| Fund | 17.03 | 26.11 | 20.25 | 15.24 | 16.79 |
| Classification | 14.95 | 22.65 | 15.66 | 12.19 | 11.14 |
| Index (S&P 500) | NA | NA | NA | NA | NA |
| % Rank in Class (1-best,100=worst) | 17 | 25 | 17 | 29 | 2 |
Fund Stats
More| Investment Objective: | Health/Biotech |
|---|---|
| Net Assets ($Mil) | 470.30 |
| Inception Date: | 6/30/99 |
| Manager Name, Tenure | Team Managed, NA |
| Expense Ratio: | 0.93% |
|
Sales Charge:
Load Type:
|
Institutional Load 0.00% 0.00% |
Top 10 Holdings (As of 10/31/12)
More| Company Name | Symbol | % Net Assets |
|---|---|---|
| Prudential Core Taxable Money Market Fund | NA | 6.60 |
| Alexion Pharmaceuticals Inc Ord | ALXN | 6.02 |
| Vertex Pharmaceuticals Inc Ord | VRTX | 5.17 |
| Biomarin Pharmaceutical Inc Ord | BMRN | 4.83 |
| Pfizer Inc Ord | PFE | 4.20 |
| Medivation Inc Ord | MDVN | 4.17 |
| Amarin Corporation Plc Dr | AMRN | 3.78 |
| Unitedhealth Group Inc Ord | UNH | 3.52 |
| Ariad Pharmaceuticals Inc Ord | ARIA | 3.23 |
| Onyx Pharmaceuticals Inc Ord | ONXX | 3.14 |
| % of Total Holdings | 44.66 | |
